PIRAMAL PHARMA LIMITED INDIA

Business Type: Manufacturer (Factory)

Piramal Pharma Limited is a prominent global pharmaceutical company based in India. It is primarily a manufacturer, operating through various integrated business segments that span the pharmaceutical value chain from drug discovery and development to manufacturing and marketing.

Overview:

Piramal Pharma Limited is a diversified global pharmaceutical company with a strong commitment to innovation, quality, and patient care. Headquartered in India, the company has established itself as a reliable partner in the healthcare industry, serving customers and patients across the world. Its operations are vertically integrated, covering critical aspects of pharmaceutical production.

Key Business Segments:

1. Piramal Pharma Solutions (PPS): This segment operates as a Contract Development and Manufacturing Organization (CDMO). It provides comprehensive, integrated services across the drug lifecycle, from drug discovery support to commercial manufacturing of Active Pharmaceutical Ingredients (APIs) and formulations for global pharmaceutical and biotech companies. This is a core manufacturing arm.

2. Piramal Critical Care (PCC): This business focuses on the development, manufacturing, and marketing of complex hospital generics, including inhalation anesthetics and injectable pain management drugs. These products are crucial for critical care settings and are manufactured in the company's facilities.

3. Consumer Healthcare: This segment is involved in the development, manufacturing, and marketing of over-the-counter (OTC) products. It offers a wide range of products across various categories, addressing everyday health and wellness needs directly to consumers. This also includes manufacturing of consumer health products.

Global Presence:

Piramal Pharma Limited boasts a significant global footprint with manufacturing facilities and research and development centers strategically located across North America, Europe, and Asia. Its products and services reach over 100 countries, reflecting its international operational capabilities and market reach.

Focus and Mission:

The company's mission is to make a meaningful difference in global health by providing high-quality, innovative pharmaceutical products and services. It prioritizes regulatory compliance, operational excellence, and sustainable practices across all its manufacturing and business activities.

Piramal Pharma Limited India produces and sells products across three primary segments.

First, through its Contract Development and Manufacturing Organization (CDMO) services, it provides comprehensive solutions for other pharmaceutical companies. This includes the development and manufacturing of Active Pharmaceutical Ingredients (APIs), including highly potent APIs and antibody-drug conjugates (ADCs). They also specialize in sterile injectables, oral solids, and offer advanced process development, analytical services, and fill-finish capabilities.

Second, its Critical Care segment offers a wide range of injectable generics primarily for hospital use. This portfolio includes inhaled anesthetics such as Sevoflurane and Isoflurane; injectable anesthetics like Propofol; pain management medications including Bupivacaine and Ropivacaine; anticoagulants such as Heparin; and various other intravenous infusions and hospital-focused injectable products.

Third, the Consumer Healthcare division focuses on over-the-counter (OTC) products catering to the Indian market. This segment comprises antacids like Polycrol; analgesics and pain relief products such as Saridon; vitamins and nutritional supplements including Supradyn; cough and cold remedies like Honitus; skin care and antiseptic products such as Lacto Calamine and I-Pill; digestive aids; women's health products; and a variety of Ayurvedic and herbal preparations.